Botulin toxin use in scars/keloids treatment

12Citations
Citations of this article
38Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Botulinum toxin (BTX) is a neurotoxin protein derived from the Clostridium botulinum bacterium that inhibits the release of acetylcholine at the neuromuscular junction level whose effects has been used for many years to treat a variety of muscular/neuromuscular conditions and more recently also for cosmetic use. BTX has experimented in some dermatological conditions which include scar prevention and treatment with good results. The complex mechanism underlying those results is not completely understood but several mechanisms were proposed: release inhibition of different substances like (TGF)-β, substance P, calcitonin gene-related peptide (CGRP) and glutamate thus modulating cutaneous inflammation and wound healing. We analysed the published data on BTX off label applications on scars and keloids retrieved from PubMed.

Author supplied keywords

Cite

CITATION STYLE

APA

Scala, J., Vojvodic, A., Vojvodic, P., Vlaskovic-Jovicevic, T., Peric-Hajzler, Z., Matovic, D., … Lotti, T. (2019). Botulin toxin use in scars/keloids treatment. Open Access Macedonian Journal of Medical Sciences, 7(18), 2979–2981. https://doi.org/10.3889/oamjms.2019.783

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free